Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Antengene discloses new ATR kinase inhibitors

Jan. 26, 2022

Hefei Amvite Pharmaceutical patents histamine H1 receptor antagonists

Jan. 26, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Medshine Discovery synthesizes new ER-alpha degradation inducers

Jan. 25, 2022

Wuhan LL Science and Technology Development divulges TRPC5 antagonists

Jan. 25, 2022

Chinese researchers patent new antibacterial compounds

Jan. 25, 2022

Suzhou Vintagence Pharma discloses new GTPase KRAS mutant inhibitors

Jan. 25, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...